22h
MedPage Today on MSNApproved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
26mon MSN
Massachusetts residents are sick and tired of paying taxes, and a new poll shows strong opposition from likely voters on Gov.
A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...
9hon MSN
The Senate is preparing to give final approval to a bill that could result in harsher prison sentences for fentanyl ...
Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...
The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.
16h
GlobalData on MSNFDA approves early feasibility study of Valcare’s transcatheter deviceThe FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.
At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results